文献速递泌尿生殖腹部CTMR

2019版Bosniak分类的临床实用性:在CT检查基础上增加磁共振成像的诊断价值

Clinical utility of the Bosniak classification version 2019: Diagnostic value of adding magnetic resonance imaging to computed tomography examination.
PubMed 文献 · Eur J Radiol · 2022-01-19

本研究纳入83例连续患者的103个囊性肾肿块,评估2019版Bosniak分类在九名读者(放射科医生、放射科住院医师、泌尿科医生各三名)中的观察者间一致性,并比较单独CT与联合CT/MRI诊断恶性肿瘤的价值。联合CT/MRI提高了住院医师和泌尿科医生的特异度和准确度,对非专家读者尤为有用。

要点

  • 联合CT/MRI在住院医师和泌尿科医生中提高了诊断恶性肿瘤的特异度和准确度。
  • 放射科医生单独CT的观察者间一致性为0.77,联合CT/MRI为0.78。
  • 以Bosniak分类≧III为恶性诊断界值,联合CT/MRI对非专家读者帮助更大。

核心结论

  • 使用BC2019诊断囊性肾肿块恶性时,联合CT/MRI有用,尤其对非专家读者。

研究设计与样本

  • 研究纳入2010至2016年间83例连续患者的103个囊性肾肿块,均行增强CT和MRI;九名读者分三组(三名放射科医生、三名放射科住院医师、三名泌尿科医生),分别单独阅CT和联合CT/MRI,使用BC2019以共识确定Bosniak分类,以≧III类为恶性诊断界值。

诊断标准与关键数值

  • 以Bosniak分类≧III为恶性诊断界值;住院医师联合CT/MRI vs 单独CT的敏感度/特异度/准确度为82.1/74.7/76.7% vs 75.0/66.7/68.9%,特异度和准确度显著更高(p=0.03和0.008);泌尿科医生联合CT/MRI vs 单独CT为78.6/73.3/74.8% vs 64.3/64.0/64.1%,敏感度/特异度/准确度均显著更高(p=0.04/0.04/0.008);放射科医生联合CT/MRI vs 单独CT为89.3/74.7/78.6% vs 85.7/73.3/76.7%,差异无统计学显著(p=0.32/0.56/0.32)。

临床应用与阅片要点

  • 对囊性肾肿块使用BC2019评估时,联合CT/MRI可提高非专家读者诊断恶性的特异度和准确度;放射科医生单独CT与联合CT/MRI的诊断效能无显著差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To assess the impact of the updated Bosniak classification (BC2019) for cystic renal masses (CRMs) on interobserver agreement between radiologists and urologists and the diagnostic value of adding MRI to CT examination (combined CT/MRI).

METHOD: This study included 103 CRMs from 83 consecutive patients assessed using contrast-enhanced CT and MRI between 2010 and 2016. Nine readers in three groups (three radiologists, three radiology residents, and three urologists) reviewed CT alone and the combined CT/MRI using BC2019. Bosniak category was determined by consensus in each group for diagnosing malignancy, with a cut-off category of ≧III. Interobserver agreement was assessed using Fleiss' kappa values. The effect of CT or combined CT/MRI on the diagnosis of malignancy was assessed using McNemar's test.

RESULTS: Interobserver agreement of BC2019 for CT alone was substantial for radiologists and residents, moderate for urologists (0.77, 0.63, and 0.58, respectively). Interobserver agreement of BC2019 for combined CT/MRI was substantial for all three groups (radiologists: 0.78; residents: 0.65; and urologists: 0.61). Among residents, the sensitivity/specificity/accuracy rates of combined CT/MRI vs. CT alone were 82.1/74.7/76.7% vs. 75.0/66.7/68.9%, and specificity and accuracy were significantly higher for combined CT/MRI than that for CT alone (p = 0.03 and 0.008, respectively). Similarly, sensitivity/specificity/accuracy values were significantly higher for combined CT/MRI among urologists (78.6/73.3/74.8% vs. 64.3/64.0/64.1%, p = 0.04/0.04/0.008). However, sensitivity/specificity/accuracy did not significantly differ between the two among radiologists (89.3/74.7/78.6% vs. 85.7/73.3/76.7%, p = 0.32/0.56/0.32).

CONCLUSIONS: Combined CT/MRI is useful for diagnosing malignancy in patients with CRMs using BC2019, especially for non-expert readers.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Arita, Yoshida, Kwee, et al. Clinical utility of the Bosniak classification version 2019: Diagnostic value of adding magnetic resonance imaging to computed tomography examination. Eur J Radiol. 2022. PMID: 35066340. doi:10.1016/j.ejrad.2022.110163

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。